643 related articles for article (PubMed ID: 29312332)
1. Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?
Wirth TC; Kühnel F
Front Immunol; 2017; 8():1848. PubMed ID: 29312332
[TBL] [Abstract][Full Text] [Related]
2. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
3. Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era.
Martin SD; Coukos G; Holt RA; Nelson BH
Ann Oncol; 2015 Dec; 26(12):2367-74. PubMed ID: 26371284
[TBL] [Abstract][Full Text] [Related]
4. Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy.
Verdon DJ; Jenkins MR
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439399
[TBL] [Abstract][Full Text] [Related]
5. Tumor neoantigens: from basic research to clinical applications.
Jiang T; Shi T; Zhang H; Hu J; Song Y; Wei J; Ren S; Zhou C
J Hematol Oncol; 2019 Sep; 12(1):93. PubMed ID: 31492199
[TBL] [Abstract][Full Text] [Related]
6. Targeting neoantigens for cancer immunotherapy.
Zhao X; Pan X; Wang Y; Zhang Y
Biomark Res; 2021 Jul; 9(1):61. PubMed ID: 34321091
[TBL] [Abstract][Full Text] [Related]
7. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.
Liu CJ; Schaettler M; Blaha DT; Bowman-Kirigin JA; Kobayashi DK; Livingstone AJ; Bender D; Miller CA; Kranz DM; Johanns TM; Dunn GP
Neuro Oncol; 2020 Sep; 22(9):1276-1288. PubMed ID: 32133512
[TBL] [Abstract][Full Text] [Related]
8. Neoantigens and their clinical applications in human gastrointestinal cancers.
Eshkiki ZS; Agah S; Tabaeian SP; Sedaghat M; Dana F; Talebi A; Akbari A
World J Surg Oncol; 2022 Sep; 20(1):321. PubMed ID: 36171610
[TBL] [Abstract][Full Text] [Related]
9. Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy.
Okada M; Shimizu K; Fujii SI
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269735
[TBL] [Abstract][Full Text] [Related]
10. Neoantigens: promising targets for cancer therapy.
Xie N; Shen G; Gao W; Huang Z; Huang C; Fu L
Signal Transduct Target Ther; 2023 Jan; 8(1):9. PubMed ID: 36604431
[TBL] [Abstract][Full Text] [Related]
11. The Role of Neoantigens in Cancer Immunotherapy.
Zhu Y; Liu J
Front Oncol; 2021; 11():682325. PubMed ID: 34513673
[TBL] [Abstract][Full Text] [Related]
12. Personalized T cell-mediated cancer immunotherapy: progress and challenges.
Bethune MT; Joglekar AV
Curr Opin Biotechnol; 2017 Dec; 48():142-152. PubMed ID: 28494274
[TBL] [Abstract][Full Text] [Related]
13. Progress in Neoantigen Targeted Cancer Immunotherapies.
Han XJ; Ma XL; Yang L; Wei YQ; Peng Y; Wei XW
Front Cell Dev Biol; 2020; 8():728. PubMed ID: 32850843
[TBL] [Abstract][Full Text] [Related]
14. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy.
Richard G; Princiotta MF; Bridon D; Martin WD; Steinberg GD; De Groot AS
Expert Rev Vaccines; 2022 Feb; 21(2):173-184. PubMed ID: 34882038
[TBL] [Abstract][Full Text] [Related]
15. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
Borden ES; Buetow KH; Wilson MA; Hastings KT
Front Oncol; 2022; 12():836821. PubMed ID: 35311072
[TBL] [Abstract][Full Text] [Related]
16. A proteogenomic approach to target neoantigens in solid tumors.
Verma A; Halder A; Marathe S; Purwar R; Srivastava S
Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
[TBL] [Abstract][Full Text] [Related]
17. Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report.
Zeng Y; Zhang W; Li Z; Zheng Y; Wang Y; Chen G; Qiu L; Ke K; Su X; Cai Z; Liu J; Liu X
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439798
[TBL] [Abstract][Full Text] [Related]
18. Identifying neoantigens for use in immunotherapy.
Hutchison S; Pritchard AL
Mamm Genome; 2018 Dec; 29(11-12):714-730. PubMed ID: 30167844
[TBL] [Abstract][Full Text] [Related]
19. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
[TBL] [Abstract][Full Text] [Related]
20. Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy.
Efremova M; Finotello F; Rieder D; Trajanoski Z
Front Immunol; 2017; 8():1679. PubMed ID: 29234329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]